ZNF154 and esophageal squamous cell carcinoma: Furthermore, ROC curve analysis showed high diagnostic efficacy of hypermethylated ZNF154 promoter for ESCC with 89.33% sensitivity and 93.65% specificity, and the optimal cut-off value of 4.92% (Fig. 1D).